| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 2.1K | 18.4% | 31.7% |
| Total Income | 2.1K | 18.1% | 31.4% |
| Expenditure | 1.9K | 18.9% | 31.7% |
| PBT | 156.89 | 9.2% | 27.8% |
| Net Profit | 103.94 | 3.6% | 14.2% |
| OPM | 11.51% | 0.14pp | 0.27pp |
| NPM | 5.02% | 1.14pp | 0.76pp |
| EPS | 7.74 | 3.7% | 14.2% |
Strong growth beat, margin pressure concerns amid capex investment
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade A
Beat prior 20% FY27 guidance (31.7% YoY). EBITDA margin 11.6% met 11%+ target. PAT margin guidance (5.5-6%) conservative vs Q2 delivery.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong structural tailwinds in transmission and distribution (₹9.15L Cr opportunity till '32) backed by ₹14.2 Cr order book and capacity roadmap deliver 31.7% YoY growth. However, QoQ PAT -3.7% despite +18.4% revenue signals margin compression from elevated depreciation/interest as capex ramps; near-term guidance maintained but realization hinges on execution and cost inflation containment.
₹2056.3 Cr
Revenue · +31.7% YoY₹103.9 Cr
Reported PAT · +14.2% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue INR2,056 Cr, 32% YoY growth
METDelivered ₹2,056.3 Cr, 31.7% YoY growth
EBITDA margin 11.6%, PAT 104 Cr up 12% YoY
METDelivered NPM 5.0%, PAT ₹103.9 Cr up 14.2% YoY
20% growth for next 3 years
METQ2 delivered 31.7% YoY, well above guidance; prior 20% FY27 target exceeded
11% plus EBITDA margin maintained
METQ2 delivered 11.5% OPM; guidance reaffirmed, on track
PAT margin 5.5-6% going forward
OVERSTATEDQ2 delivered 5.0% NPM; QoQ PAT -3.7% signals margin headwinds
Earnings quality
What changed since the last call
Order book +27% since Q1
UpgradeQ1 Q2 end order book ₹14.2K Cr vs ₹11.2K Cr inferred Q1 (from disclosure of INR1.747 Cr post-quarter orders = 15.95K Cr prospective). Large order additions visible in 5-conductor HTLS jobs (₹770 Cr) and solver project (₹400-500 MW).
Capacity roadmap accelerated
UpgradeTower capacity 1.84L → 2L tons by end FY27 (vs ₹200 Cr capex announced prior). Conductor 40.8K → 49.5K km. Re-conductoring HTLS entry (₹770 Cr awarded; margin uplift potential).
Margin pressure acknowledged vs prior confidence
DowngradePAT margin Q2 5.0% vs Q1 est. 5.4% (implied from H1 ₹212 Cr PAT / ₹3,792 Cr H1 revenue). Depreciation +35%, interest rising. Guidance to 5.5-6% effectively caps upside; not a cut but reality check.
Solar diversification advanced
New49% stake in 990 MW solar project (Maharashtra), INR3.9K Cr capex. IPP adjacent to core T&D; CFO guided revenue entry FY28. Not prior guidance; new strategic lever.
The Q&A
Analysts (Yash Kabra, Balamurali Krishna, Anurag) pressed hard on margin anomaly: revenue +32%, EBITDA +28%, PAT +12% (vs Q2 actual +14%). CFO Rajesh held firm on 11%+ EBITDA, 5.5-6% PAT guidance; attributed delta to depreciation/interest/tax rate. No concessions on near-term guidance but acknowledged capex headwinds. Tone cautious but credible.
Capacity utilization & peak revenue — Harshit, RoboCapital
AnsweredRandeep: INR12,000 Cr feasible by FY29; 20% growth minimum for next 3 yrs based on current order book and execution pace. Staggered 24-30m project cycle enables phased ramp.
Margin trajectory with capacity — Yash Kabra, Nirmal Bang
AnsweredCFO Rajesh: Interest marginally up on absolute basis but declining to revenue %. Depreciation +35% YoY from capex acceleration. Tax was one-off 25-26% normalizing; going forward PAT margin 5.5-6%. All embedded in order book quality.
HTLS re-conductoring opportunity — Deepak Purswani, SVAN Investments
AnsweredRandeep: Both product and EPC. Epsilon (French) supplying carbon core; margin in line with current strategy (margin enabler + cash flow enabler). Plant fungible across product categories.
Export mix and pricing — Sahil Patani, Stokes Capital
AnsweredRandeep: 60% domestic, 40% intl target. Hedging on commodity (aluminum for conductors); margin profile Q2 level maintained. Intl high-tariff/multinational funding drives margin selectivity.
Solar IPP financials & timeline — Balamurali Krishna, Oman Investment
PartialCFO Rajesh: ~INR500 Cr equity, balance debt (already closed). Recurring revenue; fixed tariff. CFO noted adjacent business for leverage. Revenue FY28 onwards.
BESS & data center progress — Rahul, HL Technology
PartialRandeep: Work in progress; teams being built. QIP content not finalized; 6+ months out. Expected outcome this financial year.
Order intake guidance confidence — Anurag, Indira Securities
AnsweredRandeep: Full confidence. INR10,000-odd crore order intake with 10-12% win ratio on INR30K+ Cr bidding pipeline. Backward integration (own towers/conductors) provides execution edge.
Receivables management — Balamurali Krishna
AnsweredCFO Deepak: Increase noted but focus to reduce in ensuing quarter. 82-day WC cycle maintained overall.
Product diversification timing — Balamurali Krishna
AnsweredRandeep: 2-5% product, 5-7% intent (not committed). Core T&D 85-90% stable. New products incremental, not dilutive.
Guidance
FY27 20% YoY growth maintained
HighQ2 delivered 31.7% YoY; prior guidance 20%. On track. No numeric revision.
INR10,000+ Cr annual order intake target
HighAlready INR3.5K Cr in H1; bidding pipeline INR30K+ Cr with 10-12% historical win ratio. Order book ₹14.2K Cr supports.
INR12,000 Cr revenue by FY29 feasible
MediumImplies ~20% CAGR from FY27 base. Contingent on capacity ramp, order execution, and new verticals (solar IPP, HTLS, exports) ramping on schedule.
EBITDA 11%+ maintained
HighQ2 delivered 11.6%. Cost inflation (depreciation +35%, interest rising) offset by operational leverage and capex completion benefits.
PAT margin 5.5-6% going forward
MediumQ2 5.0%, Q1 est. 5.4%. Depreciation and interest pressuring. Tax normalized from one-off 25-26%. Range acknowledges near-term headwinds but suggests recovery as capex matures.
INR3.9K Cr solar IPP capex; ~INR500 Cr equity, balance debt
HighAlready financed. Phased: 400-500 MW expected ~March '28. Recurring fixed-tariff revenue post-completion.
Core T&D capex on course; tower +200K tons, conductor +40.8K km cumulative
HighPhase 1 completed ahead of schedule. Further expansion under evaluation pending market demand and internal cash accruals.
Risks the call surfaced
Margin compression
HighDepreciation +35% YoY and interest costs rising on absolute basis eroding PAT margin from 5.4% (Q1 est.) to 5.0% (Q2). Capex cycle will sustain pressure until facilities fully amortized.
Capex execution risk
MediumTower capacity roadmap to 2L tons and conductor to 49.5K km by end FY27. Solar IPP ₹3.9K Cr capex with FY28 revenue entry. Any slippage delays order conversion and revenue recognition.
Order book concentration
MediumOrder book ₹14.2K Cr disclosed, but customer/segment mix not granularly disclosed. Large transmission/distribution projects may be concentrated with 2-3 anchor customers; loss of key customer or project delay could dent revenue.
Solar IPP execution & monetization
MediumSolar IPP (49% stake) ₹3.9K Cr capex. Revenue entry guided FY28 onwards (March 28 or later). Any project delays, PPA settlement issues, or capacity under-utilization would defer material revenue.
International market traction
LowGreenfield GIS project (Jordan), seed orders in US/Australia, international export mix targeted 40% by next 2-3y. Early-stage with pricing/margin unknown; execution risk and competitive intensity in international EPC could dent margins vs domestic.
Management
Score 8/10. Clear on numbers and strategy. Transparent on challenges (margin pressure, depreciation, capex timing). Granular on order book, capacity roadmap, and new initiatives. Some hedging on solar IPP details (CFO: 'after 6, 12 months we can answer') but not evasive. Capacity expansion Phase 1 completed ahead of schedule. Revenue guidance 20% FY27 beat (31.7% YoY Q2). Order book tracking strongly (₹14.2K Cr visible). EBITDA 11.6% sustained vs 11%+ target. PAT margins under pressure but acknowledged by management with credible root causes (depreciation, interest, tax normalization).
1 · Q3-Q4 FY27
Order book execution; tower/conductor capacity fully commissioned (2L/49.5K km)
2 · FY28
Solar IPP revenue launch (≥400-500 MW approx); re-conductoring jobs ramp
3 · H2 FY27
Greenfield GIS Jordan project (400kV/765kV lines); US/intl export traction
However, QoQ PAT -3.7% despite +18.4% revenue signals margin compression from elevated depreciation/interest as capex ramps; near-term guidance maintained but realization hinges on execution and cost inflation containment.
32% Revenue Growth, Profits Stuck in Traffic — and Why the Market Bolted
Transrail delivered a headline beat on revenue (31.7% YoY vs. prior 20% guidance) and order book momentum, but profit growth lagged badly (PAT up 14% YoY despite revenue +32%). Depreciation from capex is eating the margin — and the stock has already priced in the doubt.
₹2,056 Cr
+31.7% YoY, +18.4% QoQ
₹104 Cr
+14.2% YoY, -3.7% QoQ
11.6%
vs 11%+ guidance (met)
5.0%
vs 5.4% Q1 est. (compressed)
The numbers tell two stories. Revenue surged 32% — a beat on the prior 20% full-year guidance — and EBITDA margin held at 11.6%, meeting the 11%+ target. But profit growth flatlined relative to the top line. PAT grew 14% YoY in a quarter when revenue grew 32%. More telling: QoQ, revenue jumped 18% while PAT fell 4%. This is a capex depreciation story, not a demand or pricing story.
The profit leak: depreciation up 35%, interest rising
Management disclosed the root cause on the call without hedging. Depreciation surged 35% year-on-year because of capacity expansion capex (tower and conductor manufacturing facilities now coming onto the books). Interest costs are also rising in absolute terms as the company finances the ₹3,900 crore solar IPP (990 MW) and core T&D capex. The math: EBITDA +28% YoY, but after depreciation and interest, PAT grew only 14%. This gap is structural, not temporary — it will persist until depreciation costs amortize over the full capex cycle.
The company guided PAT margin at 5.5–6% going forward. That is effectively below Q2's 5.0% delivery (or at best level with it), signaling management expects continued near-term margin pressure. For a company posting +32% revenue growth, margin guidance that doesn't hint at upside recovery is candid about execution headwinds.
Management's claims — what holds up
Q2 revenue ₹2,056 Cr, 32% YoY growth
₹2,056.3 Cr, 31.7% YoY
Supported
EBITDA margin 11%+ maintained
11.6% delivered
Supported
20% YoY growth for next 3 years (FY27–29)
Q2 beat prior 20% guidance at 31.7%; order book ₹14.2K Cr underpins visibility
Supported
PAT margin 5.5–6% going forward
Q2 delivered 5.0%; Q1 est. 5.4%. Guidance level-to-slightly-up implies continued pressure
Credible but signals no recovery near-term
INR10,000+ Cr annual order intake achievable
Already ₹3,500 Cr in H1; bidding pipeline ₹30,000+ Cr at 10–12% historical win ratio
Supported; high confidence
What changed: order book, capacity, and new segments
Order book visibility deepened. As of quarter-end, the order backlog stood at ₹14,218 crore — up 27% from an implied ₹11,200 crore at Q1 end. Post-quarter announcements added ₹1,747 crore, lifting prospective visibility to ₹16,000 crore (roughly 6–8 quarters of run-rate at current volumes). This is concrete: large HTLS re-conductoring wins (₹770 crore in 5 jobs), greenfield GIS transmission in Jordan, and recurring pipeline orders.
Capacity roadmap accelerated on schedule. Tower manufacturing capacity expanded to 1.84 lakh metric tons per annum (target 2 lakh tons by end FY27, a +9% stretch). Conductor capacity now 40,800 km p.a., with a guided target of 49,500 km (+21% by year-end). Phase 1 of the conductor expansion was completed ahead of schedule — a credibility mark for execution. Backward integration (own tower and HTLS conductor production with Epsilon, a French partner supplying carbon cores) reduces supply chain risk and cost.
Two new segments materialized. HTLS re-conductoring (high-temperature low-sag conductors) is a margin uplift opportunity — the company won ₹770 crore in orders in Q2 with technology partner Epsilon. This is adjacent to core transmission towers but offers higher margins and insulates the company from commoditized tower competition. The solar IPP (49% stake in a 990 MW Maharashtra project) represents a ₹3,900 crore capex commitment, with revenue entry guided for FY28 onwards. Fixed-tariff recurring revenue; no volume or price risk once operational.
Revenue beat prior guidance (31.7% vs. 20% FY27 target)
Order book visibility strong (₹14.2K Cr, 6–8Q run-rate)
Capacity ramp on schedule; backward integration reduces supply risk
New HTLS and solar segments diversify and lift long-term ceiling
Operating cash flow strong (H1 ₹435 Cr vs. ₹29 Cr prior year)
PAT margin compression is real: 5.4% Q1 → 5.0% Q2 despite revenue +18% QoQ
Depreciation +35% YoY will persist until capex cycle matures (24–36m)
Profit margin guidance (5.5–6%) below organic expectation; no near-term recovery signaled
Solar IPP revenue (FY28) and international traction (US, Australia) unproven
Stock down 49% from ATH; institutional ownership (FII 2.49%) low and declining
Street positioning — why the stock crashed
Transrail trades at ₹439.5 as of November 9, 2026 — down 48.6% from its all-time high of ₹855.8. The stock sits below its 20-day (₹446.4), 50-day (₹445.0), and 200-day (₹496.7) moving averages, signaling a sustained downtrend. RSI at 47 (neutral) suggests no oversold bounce imminent. Volume is normal, not panic-driven; this is a grinding re-rating, not a capitulation.
Institutional positioning reinforces skepticism. FII ownership rose marginally to 2.49% (up 33 bps QoQ), but the absolute level is anemic for a ₹30,000+ crore bidding pipeline franchise. DII holdings dropped 163 bps to 6.52%, the lowest in the data series — institutional India is trimming, not loading. Recent bulk block deals show mixed signals: QE Securities bought 7.29 lakh shares at ₹467.93 but also sold 7.56 lakh shares at ₹465.81 (flat-price reversals); Microcurves Trading bought 10.1 lakh shares at ₹473.07 then sold the same quantity at ₹473.41 (scalping, not accumulation). No insider or promoter buying is visible. The message: even buyers are treating this as a trade, not a conviction hold.
The crash makes sense through a near-term lens. Investors expected 32% revenue growth to deliver outsized PAT growth; instead, profit lagged at +14% YoY. Margin guidance that doesn't promise recovery is a sell signal when the stock had priced in a cyclical inflection. The market has already discounted the capex depreciation drag and is pricing execution risk (solar IPP, HTLS, international) at a premium. A 49% drawdown from ATH is a real loss, but it also suggests the street has reset expectations to a more cautious baseline.
Risks, ranked by concern
Margin recovery delayed beyond 24–36 months
HighPAT margin guidance (5.5–6%) below current 5.0% signals no near-term recovery. If capex depreciation persists longer (project delays, extended amortization), margin upside is pushed further out. Investors priced in recovery; delay = re-rating downside.
Solar IPP revenue entry slips beyond FY28
HighCFO guided ₹400–500 crore+ revenue entry for FY28, representing 2% of prospective revenue but critical for diversification narrative. Project commissioning delays (common in 990 MW solar) would defer 4–8 quarters and dent credibility of '3-year 20% growth' target.
HTLS re-conductoring orders don't scale beyond ₹770 Cr
Medium₹770 crore in awarded HTLS jobs is positioned as a margin uplift and new segment. But this is a small absolute base and unproven scalability. If win rate drops or margin profile doesn't materialize, a key bull thesis (margin recovery from product mix) evaporates.
International expansion traction remains nil (US, Australia, Jordan)
MediumManagement targets 60–40 domestic-international split by FY29. Today it's ~60–40 but international is all domestic-adjacent (Jordan greenfield GIS, Australia seed orders). If international orders don't scale or margins compress in competitive bids, the growth ceiling lowers.
Input cost inflation (aluminum, copper, steel) uncontained
MediumManagement hedges commodity inputs for FY27 but acknowledged inflation is 'marginally coming down.' If labor/steel costs spike and hedges roll off, margin guidance (5.5–6%) will be tested.
Order book ₹14.2K Cr concentrated with 2–3 anchor customers
Low-MediumGranular customer mix not disclosed. Large transmission/distribution orders can be lumpy; loss of a key customer or project delay would dent revenue visibility.
Share pledge and QIP dilution ahead
LowPromoter share pledge (2–3% of capital) is due for redemption in 6–9 months; QIP for BESS/data center capex unfinalized. Dilution is manageable but adds noise.
What to watch next
1 · Q3–Q4 FY27: Capacity ramp completion and order book conversion
Target completion of tower capacity expansion to 2 lakh tons and conductor to 49,500 km by end FY27. Visible order backlog ₹14.2K Cr provides demand; watch for project execution delays (slippage would push revenue into FY28). Q3–Q4 margins matter: if depreciation momentum eases as capex tapers, profit growth should re-accelerate relative to revenue.
2 · FY28 H1: Solar IPP and HTLS revenue ramp
Solar IPP entry guided for FY28 onwards with ₹400–500 crore+ recurring revenue expected. HTLS re-conductoring (₹770 Cr awarded) should begin revenue recognition in FY28. Watch for project commissioning timeline (common risk in solar), margin profile delivery on HTLS, and order win ratio on new 5-conductor jobs. These two segments are critical to the 'margin recovery' thesis.
3 · PAT margin trajectory (near term vs. forward guidance)
The core debate. Management guided 5.5–6% PAT margin going forward, but Q2 delivered 5.0% (below the guidance band). Watch Q3–Q4 for whether margins approach the 5.5% lower bound (easing depreciation, operational leverage) or stay anchored at 5.0–5.2% (persistent capex drag, interest cost pressure). If margin stays below 5.5% through FY27-end, the 'capex cycle takes 36+ months to amortize' bear case gains credibility.
The honest read
Transrail is executing well operationally. Revenue beat guidance, order book momentum is real, capacity is ramping ahead of schedule, and the company is prudently diversifying (HTLS, solar, exports). This is not a franchise in trouble.
But near-term profit growth will disappoint relative to headline numbers because depreciation and interest are large, real, and structural. Management acknowledged this by guiding PAT margin flat-to-slightly-up (5.5–6% forward, vs. 5.0% Q2 delivery), which is effectively a reality check. For investors expecting profit to decelerate no more than revenue, the quarter is a letdown.
The bull case — 20% multi-year growth with margin recovery — is 24–36 months out. The bear case — margins stay pinned below 5.5% for another 4–6 quarters, delaying capex ROI realization — is plausible and priced in by the market (stock down 49% from ATH). The stock's 49% drawdown is a real market judgment that this is a steady execution story, not a step-change growth inflection. Until margins trend visibly toward the 5.5–6% band (probably not until late FY27 or FY28), institutional investors will remain cautious.
For a holder or entrant, the number to track from here is the PAT margin trajectory through Q3–Q4 FY27. If margins hold at 5.0–5.2%, the capex drag is more durable than management implies. If margins push above 5.4%, the recovery thesis gains traction and the 49% drawdown becomes a re-entry opportunity. That's the pivot.
Transrail delivered a solid operational quarter: 32% revenue growth, order book up 27%, capacity ramp on track. But the margin lag — profit growth only 14% YoY despite revenue +32%, with PAT falling 4% QoQ — is the real story. Depreciation and interest are eating profits in the short term. Management's flat-to-up margin guidance (5.5–6% forward) is credible but signals no near-term recovery. The market's 49% drawdown reflects this skepticism. The stock is a 24–36 month conviction hold (when capex amortization eases), not a near-term trade. Watch the PAT margin trend through FY27-end to validate or disprove the recovery thesis.